The children’s COVID-19 vaccine rollout requires a different playbook

Now that the FDA approved emergency-use authorization of the Pfizer-BioNTech COVID-19 vaccine for children 5 to 11 years old, it’s essential for as many as possible to get vaccinated. But successfully rolling out the vaccine to young children will require a different approach than for adults. The FDA approval represents a watershed moment in the fight against COVID-19, yet many parents, even those who are vaccinated themselves, are hesitant to vaccinate their children.